SynthesisNeurosurgery2026
Standalone Meningioma Embolization: A Systematic Review.
Synthesis in Neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesMeningiomas are the most common primary intracranial tumors, with over 450 000 new cases each year. Although surgical resection remains the standard of care, recurrence occurs in up to 40% of cases. Reoperation poses additional risks due to anatomic changes and scar tissue. Elderly and frail patients experience increased rates of surgical morbidity, limiting treatment options. This study evaluates the potential of embolization, a technique traditionally used preoperatively to reduce intraoperative blood loss, as a definitive or palliative standalone treatment in select cases.
methodsA systematic review was conducted following Preferred Reporting Items for System reviews and Meta-Analyses guidelines. PubMed/MEDLINE and EMBASE were searched for studies reporting standalone meningioma embolization, defined as embolization without resection or radiotherapy for at least 2 months postprocedure. Two blinded reviewers screened articles using Covidence and conducted standardized data extraction. Variables collected included patient demographics, tumor characteristics, embolic agents, outcomes, and complications.
resultsThis review identified 121 patients across 34 studies treated with standalone embolization. Of these, 67 patients had long-term follow-up. Symptomatic improvement was reported in 77 ± 6% of symptomatic patients, with radiographic tumor shrinkage observed in 84 ± 6%, and complete resolution seen in 5%. The major complication rate (5%) was comparable with that of preoperative embolization (3%-6%) and lower than that of surgical resection (7%-31%).
conclusionStandalone embolization potentially represents a lower-risk alternative for meningioma patients unsuitable for surgery or refractory to standard treatments. Although current evidence is limited and largely retrospective, reported outcomes support further prospective investigation. Mechanistically, ischemia-induced necrosis may be the underlying cause of tumor and symptom regression. Larger studies are needed to establish standalone embolization as a safe and effective meningioma treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.